Literature DB >> 2466591

Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations.

M Heike1, U Möbius, A Knuth, S Meuer, K H Meyer zum Büschenfelde.   

Abstract

The recently described Ta1 antigen is expressed by activated T cells in vitro and in vivo, as observed in patients with certain immune-mediated diseases, such as multiple sclerosis. In this paper we report on the tissue distribution of the Ta1 antigen. Serological testing of human tumour cell lines and immunohistochemical analysis of human tissue sections revealed a reactivity of the anti-Ta1 antibody with normal and malignant tissues of the upper gastro-intestinal tract, the biliary tract, exocrine pancreas and kidney. SDS-PAGE analysis of immunoprecipitates from 125I-labelled cells, employing the anti-Ta1 antibody, yielded a 113-115 kD band from three serologically Ta1 positive tumour cell lines, from a serologically Ta1 negative human EBV-transformed B lymphoblastoid cell line, from peripheral blood mononuclear cells (PBMC) and, as previously described, a 105 kD band from PHA activated T cells (Fox et al., 1984). After endoglycosidase F treatment similar bands of 85 kD were precipitated from activated T cells and from tumour cell lines. It is therefore likely that very similar glycoproteins, which differ only modestly in the size of carbohydrate chains, bear the Ta1 epitope on Ta1 positive tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466591      PMCID: PMC1542019     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Antigen reactive memory T cells are defined by Ta1.

Authors:  D A Hafler; D A Fox; D Benjamin; H L Weiner
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

2.  Triggering of the lethal hit in human cytotoxic T lymphocytes: a functional role for a 103-kDa T cell-specific activation antigen.

Authors:  B Fleischer; D J Schendel; D Von Steldern
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.

Authors:  D A Fox; R E Hussey; K A Fitzgerald; O Acuto; C Poole; L Palley; J F Daley; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  Identification and characterization of human T lymphocyte antigens.

Authors:  P L Romain; O Acuto; S F Schlossman
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  A one-step purification of membrane proteins using a high efficiency immunomatrix.

Authors:  C Schneider; R A Newman; D R Sutherland; U Asser; M F Greaves
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

7.  Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins.

Authors:  M Morrison
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D A Hafler; D A Fox; M E Manning; S F Schlossman; E L Reinherz; H L Weiner
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

9.  The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.

Authors:  T A Waldmann
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

10.  Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody.

Authors:  W G Dippold; R Klingel; H Bernhard; H P Dienes; A Knuth; K H Meyer zum Büschenfelde
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

View more
  14 in total

1.  Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15.

Authors:  T Yamabe; K Takakura; K Sugie; Y Kitaoka; S Takeda; Y Okubo; K Teshigawara; J Yodoi; T Hori
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

Review 2.  Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.

Authors:  A Zarrinpar; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-10-11       Impact factor: 8.171

3.  G1/S cell cycle arrest provoked in human T cells by antibody to CD26.

Authors:  Kei Ohnuma; Tomonori Ishii; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Masahiko Uchiyama; Hirotoshi Tanaka; Tadanori Yamochi; Nam H Dang; Chikao Morimoto
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

4.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

Review 5.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

6.  Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.

Authors:  Sumaiya Chowdhury; Yiqian Chen; Tsun-Wen Yao; Katerina Ajami; Xin M Wang; Yury Popov; Detlef Schuppan; Patrick Bertolino; Geoffrey W McCaughan; Denise Mt Yu; Mark D Gorrell
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

7.  Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

Authors:  C Morimoto; C I Lord; C Zhang; J S Duke-Cohan; N L Letvin; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene.

Authors:  C A Abbott; E Baker; G R Sutherland; G W McCaughan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression.

Authors:  H J Choi; J Y Kim; S-C Lim; G Kim; H J Yun; H S Choi
Journal:  Br J Pharmacol       Date:  2015-10-16       Impact factor: 8.739

10.  The in vivo expression of dipeptidyl peptidases 8 and 9.

Authors:  Denise M T Yu; Katerina Ajami; Margaret G Gall; Joohong Park; C Soon Lee; Kathryn A Evans; Eileen A McLaughlin; Melissa R Pitman; Catherine A Abbott; Geoffrey W McCaughan; Mark D Gorrell
Journal:  J Histochem Cytochem       Date:  2009-07-06       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.